Responses

PDF

OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998–2016
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Tool now includes 2017 data (update from the author)

    In this paper we described how we created an open-data exploration tool at OpenPrescribing.net by compiling and normalising England’s national prescribing data for 1998–2016 [1], with the aim of facilitating the exploration of long-term prescribing trends. We have now updated this tool to include the data for 2017, which was released in March. Anyone can access our data tool at OpenPrescribing.net/long-term-trends.

    The Office for National Statistics does not release official mid-year population estimates for the previous year until June. Until then, for 2017 we have used their projected England population figure [2] and will update the tool again with the final figure when available.

    Our tool shows that the total number of items prescribed in 2017 increased marginally on the previous year, with a slight reduction in overall cost, across the core chapters (1-15) of the British National Formulary (BNF). The sections with the greatest increase in cost were Drugs used in Diabetes (+£7.8k inflation-corrected cost per 1,000 population) and Anticoagulants and Protamine (+£6.5k), whereas Lipid-Regulating Drugs decreased by £5.2k. Antidepressant Drugs have seen the largest increase in prescribing (+464 items per 1,000 population). Users can use the tool to explore the data down to the level of individual brands for each chemical substance.

    A further improvement to the tool was also carried out recently, to smooth out sudden increases and decreases in prescribi...

    Show More
    Conflict of Interest:
    None declared.